Description:GSK-923295, with the CAS number 1088965-37-0, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in the field of oncology. It functions as a selective inhibitor of certain protein kinases, which play crucial roles in cell signaling pathways that regulate cell growth, division, and survival. The compound's mechanism of action typically involves the modulation of specific pathways associated with cancer cell proliferation and survival, making it a candidate for targeted cancer therapies. In terms of its physical and chemical properties, GSK-923295 is characterized by its molecular structure, which includes specific functional groups that contribute to its biological activity and solubility. As with many investigational compounds, detailed studies on its pharmacokinetics, toxicity, and efficacy are essential for understanding its potential as a therapeutic agent. Further research is necessary to fully elucidate its characteristics and applications in clinical settings.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
